biotech
Flavopiridol and Cisplatin Combination May Be Effective Against Platinum-Resistant Ovarian Cancer
Filed in archive Drugs, Vaccines and Therapeutics by ruth on October 25, 2007
Flavopiridol and Cisplatin Combination May Be Effective Against Platinum-Resistant Ovarian Cancer
Mayo Clinic has reported positive preliminary results in the Phase 11 clinical trials of a new combination therapy using flavopiridol (an investigational anti-cancer agent that also boosts the effects of other therapeutics including cisplatin) with cisplatin (a platinum compound) for women with platinum-resistant ovarian or primary peritoneal (lining of the abdominal cavity) cancers.
Of the 18 patients, all of whom were receiving the therapy as a second-line treatment after disease progression, one patient experienced complete response (all signs of cancer gone) and five other patients experienced partial responses (tumor regression). The 33 percent overall response rate (6 of 18 patients) is about twice as high as seen using traditional chemotherapy regimens.

The researchers also offered the combination therapy to five patients with platinum-sensitive (original therapy resulted in no recurrence for greater than 12 months) ovarian cancer. Of these women, one experienced complete response and three others partial response.

The researchers are now planning on expanding the trial to verify the results. Read more from the Mayo Clinic report.

Permalink: Flavopiridol and Cisplatin Combination May Be Effective Against Platinum-Resistant Ovarian Cancer
Tags: cancer  ovarian+cancer  ovary+cancer  chemotherapy  cisplatin  flavopiridol  biotech  platinum+resistant 
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/98698
img Addthis img Ask img Blinklist img del.icio.us img Digg img Fark img Facebook img Google img Lycos img Ma.gnolia Add this page to Mister Wong Mr Wong img Netscape img Netvousz img Newsvine img Reddit img StumbleUpon img Slashdot img Tailrank img Technorati img Wink img Yahoo

Vote for Flavopiridol and Cisplatin Combination May Be Effective Against Platinum-Resistant Ovarian Cancer:

  • Currently 7.25/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 7.25 out of 4 vote(s) cast.
Subscribe
Share It
Popular posts from our other blogs:
RSSrss
See all blog subscribe options
Google google
What is RSS?
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Newsletter

TwitterFollow us on Twitter!